Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cervico-Thoracic Spinal Dural Arteriovenous Fistula in a Patient with Lower Extremity Weakness Exacerbated by Steroids and Lumbar Puncture
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
13-005
Spinal dural arteriovenous fistula (SDAVF) is a rare condition and an uncommon cause of myelopathy. They are most commonly located in the thoracolumbar region and typically present with lower extremity weakness in males in their 5th and 6th decade of life.
NA
Case report.

A 73-year-old female presented with 2 days of progressively worsening lower extremity weakness. Examination demonstrated 4/5 strength in proximal lower extremities and 5/5 strength distally, hyperreflexia and bilateral Babinski signs. MRI of the cervical and thoracic spine revealed cord signal changes from C5 to T5. She was empirically treated with methylprednisolone for presumed transverse myelitis. The following day strength testing revealed 4-/5 strength proximally, 5/5 distally, and worsening urinary incontinence. The patient underwent a lumbar puncture that day following which her lower extremities strength was 0/5 proximally and 1/5 distally with new complete sensory loss below T10.

Repeat spine MRI revealed persistent signal changes and the presence of flow voids along the cervical spine. SDAVF was suspected, with spinal angiography revealing a single arterial feeder from the right deep ascending cervical artery at the C4-C5 vertebrae. The patient underwent successful embolization of the vessel. Lower extremity strength improved slightly to 2/5 distally and 1/5 proximally at the time of discharge, and to 4/5 distally and 3/5 proximally 3 months later following rehabilitation.

This case of SDAVF affecting the lower cervical spine illustrates an important but often forgotten feature of SDAVF, the exacerbation of symptoms by both steroids and lumbar puncture. Careful review of imaging and high clinical suspicion is vital to prevent iatrogenic complications in these patients.
Authors/Disclosures
Sukhraj Gill, MD
PRESENTER
Dr. Gill has nothing to disclose.
Sandeep Gill, MD (Aurathirty2) Dr. Gill has nothing to disclose.
Matthew Hart, MD (Matthew Hart) Dr. Hart has nothing to disclose.
Mitchell Onken, MD (Geisinger Medical Center) Dr. Onken has nothing to disclose.